Cytori Therapeutics, Inc. Names John Ransom, Ph.D., Vice President Of Research, Regenerative Cell Technology

SAN DIEGO--(BUSINESS WIRE)--Dec. 14, 2005--Cytori Therapeutics, Inc. (Frankfurt: XMPA) announced today the appointment of John Ransom, Ph.D., to Vice President of Research, Regenerative Cell Technology. Dr. Ransom will direct the Company’s adipose stem and regenerative cell therapy discovery efforts.

MORE ON THIS TOPIC